Immune responses of infants to infection with respiratory viruses and live attenuated respiratory virus candidate vaccines.

No abstract is available for this paper.

• Publication year

  1998

• Venue

  Vaccine

• Publication date

  1998-08-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/S0264-410X(98)00103-0PMID 9711783
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Plasma proteins of the bronchoalveolar surface of the lungs of smokers and nonsmokers.

  2015cited by this paper
• Raynaud ' s disease : a critical review of minimal requisites for diagnosis

  2006cited by this paper
• Respiratory syncytial virus (RSV) immune globulin intravenous therapy for RSV lower respiratory tract infection in infants and young children at high risk for severe RSV infections: Respiratory Syncytial Virus Immune Globulin Study Group.

  1997cited by this paper
• Influenza among hospitalized adults with leukemia.

  1997cited by this paper
• Evaluation of bivalent live attenuated influenza A vaccines in children 2 months to 3 years of age: safety, immunogenicity and dose-response.

  1997cited by this paper
• Nosocomial Respiratory Syncytial Virus Infections Prevention and Control in Bone Marrow Transplant Patients

  1997cited by this paper
• Respiratory Syncytial Virus (RSV) Immune Globulin Intravenous Therapy for RSV Lower Respiratory Tract Infection in Infants and Young Children at High Risk for Severe RSV Infections

  1997cited by this paper
• Evaluation of two live, cold-passaged, temperature-sensitive respiratory syncytial virus vaccines in chimpanzees and in human adults, infants, and children.

  1997cited by this paper
• Community respiratory virus infections among hospitalized adult bone marrow transplant recipients.

  1996cited by this paper
• Effective immunization with live attenuated influenza A virus can be achieved in early infancy. Pediatric Care Center.

  1996cited by this paper
• Live subgroup B respiratory syncytial virus vaccines that are attenuated, genetically stable, and immunogenic in rodents and nonhuman primates.

  1996cited by this paper
• Respiratory disease due to parainfluenza virus in adult bone marrow transplant recipients.

  1996cited by this paper
• Rapid diagnosis of respiratory syncytial virus infections in immunocompromised adults

  1996cited by this paper
• Evaluation of a live attenuated bovine parainfluenza type 3 vaccine in two- to six-month-old infants.

  1996cited by this paper
• Isolation and characterization of a highly attenuated respiratory syncytial virus (RSV) vaccine candidate by mutagenesis of the incompletely attenuated RSV A2 ts-1 NG-1 mutant virus.

  1995cited by this paper
• A live attenuated bovine parainfluenza virus type 3 vaccine is safe, infectious, immunogenic, and phenotypically stable in infants and children.

  1995cited by this paper
• Safety and immunogenicity of a cold‐adapted influenza A (H1N1) reassortant virus vaccine administered to infants less than six months of age

  1995cited by this paper
• Epidemiology of Influenza A virus infection in patients with acute or chronic leukemia

  1995cited by this paper
• Respiratory syncytial virus pneumonia in hospitalized adult patients with leukemia.

  1995cited by this paper
• Cold-passaged, temperature-sensitive mutants of human respiratory syncytial virus (RSV) are highly attenuated, immunogenic, and protective in seronegative chimpanzees, even when RSV antibodies are infused shortly before immunization.

  1995cited by this paper
• Different kinetics of antibody responses between IgA and IgG classes in nasopharyngeal secretion in infants and children during primary respiratory syncytial virus infection

  1995cited by this paper
• A live human parainfluenza type 3 virus vaccine is attenuated and immunogenic in healthy infants and children.

  1995cited by this paper
• Satisfactorily attenuated and protective mutants derived from a partially attenuated cold-passaged respiratory syncytial virus mutant by introduction of additional attenuating mutations during chemical mutagenesis.

  1994cited by this paper
• Respiratory syncytial virus group-specific antibody response in nasopharyngeal secretions from infants and children after primary infection.

  1994cited by this paper
• Cytokine response to respiratory syncytial virus stimulation of human peripheral blood mononuclear cells.

  1994cited by this paper
• A randomized controlled trial of cold-adapted and inactivated vaccines for the prevention of influenza A disease.

  1994cited by this paper
• Recombinant human respiratory syncytial virus (RSV) monoclonal antibody Fab is effective therapeutically when introduced directly into the lungs of RSV-infected mice.

  1994cited by this paper
• A further attenuated derivative of a cold-passaged temperature-sensitive mutant of human respiratory syncytial virus retains immunogenicity and protective efficacy against wild-type challenge in seronegative chimpanzees.

  1994cited by this paper
• Effect of maternal antibody on IgA antibody response in nasopharyngeal secretion in infants and children during primary respiratory syncytial virus infection.

  1994cited by this paper
• Influenza A virus infections among hospitalized adult bone marrow transplant recipients.

  1994cited by this paper
• Respiratory syncytial virus-specific cell-mediated immune responses after vaccination with a purified fusion protein subunit vaccine.

  1994cited by this paper
• Multidose, live attenuated, cold-recombinant, trivalent influenza vaccine in infants and young children.

  1994cited by this paper
• Prophylactic Administration of Respiratory Syncytial Virus Immune Globulin to High-Risk Infants and Young Children

  1993cited by this paper
• Comparison of monovalent and trivalent live attenuated influenza vaccines in young children.

  1993cited by this paper
• Effect of heterosubtypic immunity on infection with attenuated influenza A virus vaccines in young children

  1993cited by this paper
• Respiratory syncytial virus-specific immunoglobulins in preterm infants.

  1993cited by this paper
• Prophylactic administration of respiratory syncytial virus immune globulin to high-risk infants and young children. The Respiratory Syncytial Virus Immune Globulin Study Group.

  1993cited by this paper
• Parainfluenza virus infection in adult bone marrow transplant recipients

  1993cited by this paper
• Safety and immunogenicity of a recombinant protein influenza A vaccine in adult human volunteers and protective efficacy against wild-type H1N1 virus challenge.

  1993cited by this paper
• Evaluation of immunoglobulin E-specific antibodies and viral antigens in nasopharyngeal secretions of children with respiratory syncytial virus infections

  1993cited by this paper
• Studies on reactogenicity and immunogenicity of attenuated bivalent cold recombinant influenza type A (CRA) and inactivated trivalent influenza virus (TI) vaccines in infants and young children.

  1993cited by this paper
• Evaluation of a live attenuated, cold-adapted parainfluenza virus type 3 vaccine in children

  1992cited by this paper
• Immunization of infants and young children with live attenuated trivalent cold-recombinant influenza A H1N1, H3N2, and B vaccine.

  1992cited by this paper
• Severe respiratory syncytial virus pneumonia after autologous bone marrow transplantation: a report of three cases and review.

  1992cited by this paper
• An outbreak of respiratory syncytial virus in a bone marrow transplant center.

  1992cited by this paper
• Immunoglobulin G antibody avidity in patients with respiratory syncytial virus infection

  1992cited by this paper
• Effect of passive antibody on the immune response of cotton rats to purified F and G glycoproteins of respiratory syncytial virus (RSV).

  1991cited by this paper
• Group-specific serum antibody responses in children with primary and recurrent respiratory syncytial virus infections.

  1991cited by this paper
• The A/Mallard/6750/78 avian-human, but not the A/Ann Arbor/6/60 cold-adapted, influenza A/Kawasaki/86 (H1N1) reassortant virus vaccine retains partial virulence for infants and children.

  1991cited by this paper
• Immunity to and frequency of reinfection with respiratory syncytial virus.

  1991cited by this paper
• Evaluation of bovine, cold-adapted human, and wild-type human parainfluenza type 3 viruses in adult volunteers and in chimpanzees

  1991cited by this paper
• Antibody responses of humans and nonhuman primates to individual antigenic sites of the hemagglutinin-neuraminidase and fusion glycoproteins after primary infection or reinfection with parainfluenza type 3 virus

  1990cited by this paper
• Comparison of live attenuated cold-adapted and avian-human influenza A/Bethesda/85 (H3N2) reassortant virus vaccines in infants and children.

  1990cited by this paper
• Evaluation of cold-recombinant influenza A/Korea (CR-59) virus vaccine in infants

  1989cited by this paper
• Respiratory syncytial virus-specific antibody responses in immunoglobulin A and E isotypes to the F and G proteins and to intact virus after natural infection

  1989cited by this paper
• Immunoglobulin A antibody response to respiratory syncytial virus structural proteins in colostrum and milk

  1989cited by this paper
• Immunoglobulin‐class‐specific immune response to respiratory syncytial virus structural proteins in infants, children, and adults

  1989cited by this paper
• Development of cell‐mediated cytotoxic immunity to respiratory syncytial virus in human infants following naturally acquired infection

  1989cited by this paper
• Serum immunoglobulin G antibody subclass response to respiratory syncytial virus F and G glycoproteins after first, second, and third infections

  1989cited by this paper
• Immunosuppression of the antibody response to respiratory syncytial virus (RSV) by pre-existing serum antibodies: partial prevention by topical infection of the respiratory tract with vaccinia virus-RSV recombinants.

  1989cited by this paper
• Respiratory syncytial virus infection in immunocompromised adults.

  1988cited by this paper
• Attenuation of bovine parainfluenza virus type 3 in nonhuman primates and its ability to confer immunity to human parainfluenza virus type 3 challenge.

  1988cited by this paper
• Passive transfer of respiratory syncytial virus (RSV) antiserum suppresses the immune response to the RSV fusion (F) and large (G) glycoproteins expressed by recombinant vaccinia viruses

  1988cited by this paper
• Strain-specific serum antibody responses in infants undergoing primary infection with respiratory syncytial virus.

  1988cited by this paper
• Rapid detection of respiratory syncytial virus in clinical specimens.

  1987cited by this paper
• Antigenic relatedness between glycoproteins of human respiratory syncytial virus subgroups A and B: evaluation of the contributions of F and G glycoproteins to immunity

  1987cited by this paper
• Differential immunoglobulin G subclass antibody titers to respiratory syncytial virus F and G glycoproteins in adults

  1987cited by this paper
• Cell-mediated cytotoxic response to respiratory syncytial virus in infants with bronchiolitis.

  1987cited by this paper
• Relation of Serum Antibody to Glycoproteins of Respiratory Syncytial Virus with Immunity to Infection in Children

  1987cited by this paper
• Effectiveness of topically administered neutralizing antibodies in experimental immunotherapy of respiratory syncytial virus infection in cotton rats

  1987cited by this paper
• Serum immunoglobulin G antibody subclass responses to respiratory syncytial virus F and G glycoproteins after primary infection

  1986cited by this paper
• Recognition of influenza A virus nucleoprotein by human cytotoxic T lymphocytes.

  1986cited by this paper
• Dissociation between serum neutralizing and glycoprotein antibody responses of infants and children who received inactivated respiratory syncytial virus vaccine

  1986cited by this paper
• Parainfluenza virus bronchiolitis. Epidemiology and pathogenesis.

  1986cited by this paper
• A neutralizing monoclonal antibody to respiratory syncytial virus which binds to both F1 and F2 components of the fusion protein.

  1986cited by this paper
• Serum and nasal-wash immunoglobulin G and A antibody response of infants and children to respiratory syncytial virus F and G glycoproteins following primary infection

  1986cited by this paper
• Immunity to influenza A virus infection in young children: a comparison of natural infection, live cold-adapted vaccine, and inactivated vaccine.

  1986cited by this paper
• Respiratory syncytial viral infection in children with compromised immune function.

  1986cited by this paper
• Age related IgG subclass response to respiratory syncytial virus fusion protein in infected infants.

  1986cited by this paper
• Human and murine cytotoxic T cells specific to respiratory syncytial virus recognize the viral nucleoprotein (N), but not the major glycoprotein (G), expressed by vaccinia virus recombinants.

  1986cited by this paper
• Development and characterization of cold-adapted viruses for use as live virus vaccines.

  1985cited by this paper
• Antibody response to respiratory syncytial virus structural proteins in children with acute respiratory syncytial virus infection

  1985cited by this paper
• Immunoprophylaxis and immunotherapy of respiratory syncytial virus infection in the cotton rat.

  1985cited by this paper
• Respiratory Syncytial Virus-Specific IgE Responses following Infection: Evidence for a Predominantly Mucosal Response

  1985cited by this paper
• Immunoglobulin G subclass antibody responses in influenza A and parainfluenza type 1 virus infections.

  1985cited by this paper
• Detection of RS‐virus IgG‐subclass‐ specific antibodies: Variation according to age in infants and small children and diagnostic value in RS‐virus‐infected small infants

  1985cited by this paper
• Use of influenza A virus vaccines in seronegative children: live cold-adapted versus inactivated whole virus.

  1985cited by this paper
• Quantitative aspects of passive immunity to respiratory syncytial virus infection in infant cotton rats

  1985cited by this paper
• Protection from respiratory syncytial virus infection in cotton rats by passive transfer of monoclonal antibodies

  1984cited by this paper
• Cell‐mediated immunity in respiratory syncytial virus disease

  1984cited by this paper
• Live attenuated influenza A virus vaccines in children: results of a field trial.

  1984cited by this paper
• Parainfluenza virus type 3: seasonality and risk of infection and reinfection in young children.

  1984cited by this paper
• Monoclonal antibodies protect against respiratory syncytial virus infection in mice.

  1984cited by this paper
• Variation in frequency of natural reinfection with influenza A viruses

  1983cited by this paper
• Plasma membranes from influenza virus-infected cells induce in vitro human secondary virus-specific cytotoxic T lymphocyte responses.

  1983cited by this paper
• Antibodies to respiratory syncytial virus polypeptides and their significance in human infection.

  1983cited by this paper
• Individuals infected with two subtypes of influenza A virus in the same season.

  1983cited by this paper
• Declining T-cell immunity to influenza, 1977-82.

  1983cited by this paper
• Cytotoxic T-cell immunity to influenza.

  1983cited by this paper
• Characterization of the human peripheral blood effector cells mediating antibody-dependent cell-mediated cytotoxicity against respiratory syncytial virus.

  1983cited by this paper

• Genomika i molekularna epidemiologija virusa iz porodica Paramyxoviridae i Pneumoviridae u Hrvatskoj

  2018cites this paper
• 3 Animal Models of Respiratory Syncytial Virus Pathogenesis and Vaccine Development : Opportunities and Future Directions

  2018cites this paper
• 122 – Host Defense Mechanisms Against Viruses

  2017cites this paper
• Human Respiratory Syncytial Virus Infection 44 due to formaldehyde treatment and / or poor Toll-like receptor stimulation by inactivated

  2017cites this paper
• The uptake, safety and effectiveness of seasonal influenza vaccination during pregnancy: an evaluation of the maternal influenza immunisation program in Western Australia

  2016cites this paper
• The respiratory syncytial virus fusion protein formulated with a novel combination adjuvant induces balanced immune responses in lambs with maternal antibodies.

  2015cites this paper
• respiratory syncytial virus fusion protein formulated with a novel ombination adjuvant induces balanced immune responses in lambs ith maternal antibodies

  2015cites this paper
• Animal Models of Respiratory Syncytial Virus Pathogenesis and Vaccine Development: Opportunities and Future Directions

  2011cites this paper
• Listeria monocytogenes (delta-actA mutant) infection in tumor necrosis factor receptor p55-deficient neonatal mice.

  2010cites this paper
• Vascular endothelial growth factor in developing ovine lung: endogenous expression and effec ts of exogenous administration on respiratory syncytial virus infection

  2010cites this paper
• Respiratory syncytial virus: back to basics.

  2009cites this paper
• Common Pediatric Conditions—East and West

  2009cites this paper
• Disease intervention strategies against respiratory syncytial virus infection

  2009influential citation
• RNA Interference Inhibits Respiratory Syncytial Virus Replication and Disease Pathogenesis without Inhibiting Priming of the Memory Immune Response

  2008cites this paper
• Regulation of Immunity to Respiratory Syncytial Virus by Dendritic Cells, Toll-Like Receptors, and Notch

  2008cites this paper
• Iridium Oxide Film-Enhanced Impedance Immunosensor for Rapid Detection of Carcinoembyronic Antigen

  2007cites this paper
• Neonatal human autologous dendritic cells pulsed with recombinant protein antigen prime the generation of non-polarized CD4 T-cell effectors.

  2007cites this paper
• Kapitel 10 – Häufige Erkankungen im Kindesalter aus westlicher und chinesischer Sicht

  2007cites this paper
• Transcriptional control of activation-induced cytidine deaminase and error-prone DNA polymerases is functionally mature in the B cells of infants at birth.

  2006cites this paper
• Vaccines to prevent transmission of HIV-1 via breastmilk: scientific and logistical priorities.

  2006cites this paper
• Rotavirus-specific CD5+ B cells in young children exhibit a distinct antibody repertoire compared with CD5- B cells.

  2006cites this paper
• Common Respiratory Viruses and Pulmonary Mucosal Immunology

  2006cites this paper
• Co-immunization of BALB/c mice with recombinant immunogens containing G protein fragment and chimeric CTL epitope of respiratory syncytial virus induces enhanced cellular immunity and high level of antibody response.

  2005cites this paper
• Quartz crystal microbalance detection of glutathione-protected nanoclusters using antibody recognition.

  2005cites this paper
• Autocrine IL‐10 partially prevents differentiation of neonatal dendritic epidermal leukocytes into Langerhans cells

  2004cites this paper
• Influence of Promoter Variants of Interleukin-10, Interleukin-9, and Tumor Necrosis Factor– a Genes on Respiratory Syncytial Virus Bronchiolitis

  2004cites this paper
• Influence of promoter variants of interleukin-10, interleukin-9, and tumor necrosis factor-alpha genes on respiratory syncytial virus bronchiolitis.

  2004cites this paper
• Effects of Human Metapneumovirus and Respiratory Syncytial Virus Antigen Insertion in Two 3′ Proximal Genome Positions of Bovine/Human Parainfluenza Virus Type 3 on Virus Replication and Immunogenicity

  2003cites this paper
• Respiratory syncytial virus vaccine: Is it coming?

  2003cites this paper
• Variable Gene Repertoires Rotavirus Share Common Immunodominant Infant and Adult Human B Cell Responses to

  2003cites this paper
• Effect of maternal antibodies on the infant immune response.

  2003cites this paper
• Efficient priming of antigen-specific cytotoxic T lymphocytes by human cord blood dendritic cells.

  2003cites this paper
• Viral otitis media

  2003cites this paper
• Infant and Adult Human B Cell Responses to Rotavirus Share Common Immunodominant Variable Gene Repertoires 1

  2003cites this paper
• Determinants of the Host Range Restriction of Replication of Bovine Parainfluenza Virus Type 3 in Rhesus Monkeys Are Polygenic

  2003cites this paper
• Inability To Evoke a Long-Lasting Protective Immune Response to Respiratory Syncytial Virus Infection in Mice Correlates with Ineffective Nasal Antibody Responses

  2003cites this paper
• Acute respiratory illness incidence and death among children under two years of age on Lombok Island, Indonesia.

  2002cites this paper
• Influenza virosomes are an efficient delivery system for respiratory syncytial virus-F antigen inducing humoral and cell-mediated immunity.

  2002cites this paper
• Current concepts on active immunization against respiratory syncytial virus for infants and young children

  2002cites this paper
• Recent advances in otitis media. 7. Vaccine.

  2002cites this paper
• Respiratory syncytial virus infections in children and adults.

  2002cites this paper
• Potential therapeutic implications of new insights into respiratory syncytial virus disease

  2002cites this paper
• Respiratory Syncytial Virus Vaccines Mice Immunized with Live Attenuated Humoral But Not Cell-Mediated Immunity in Passively Acquired Antibodies Suppress

  2001cites this paper
• Pathogenesis of RSV lower respiratory tract infection: implications for vaccine development.

  2001cites this paper
• Maternal vaccines.

  2001cites this paper
• A single amino acid substitution in the viral polymerase creates a temperature-sensitive and attenuated recombinant bovine parainfluenza virus type 3.

  2001cites this paper
• Human parainfluenza virus-associated hospitalizations among children less than five years of age in the United States

  2001cites this paper
• Passively Acquired Antibodies Suppress Humoral But Not Cell-Mediated Immunity in Mice Immunized with Live Attenuated Respiratory Syncytial Virus Vaccines

  2001cites this paper
• Prevention of respiratory syncytial virus infections.

  2001cites this paper
• Influence of maternal antibodies on neonatal immunization against respiratory viruses.

  2001cites this paper
• Active Immunization in the United States: Developments over the Past Decade

  2001cites this paper
• Expression and characterization of soluble human parainfluenza virus type 1 hemagglutinin-neuraminidase glycoprotein.

  2001cites this paper
• Evaluation of a live, cold-passaged, temperature-sensitive, respiratory syncytial virus vaccine candidate in infancy.

  2000cites this paper
• Aktuelle Ansätze zur Impfstoffentwicklung gegen Respiratory-Syncytial-Virus (RSV)

  2000cites this paper
• Treatment and prevention of respiratory syncytial virus infection

  2000cites this paper
• A Serious Outbreak of Parainfluenza Type 3 On a Nursing Unit

  2000cites this paper
• Respiratory syncytial virus (RSV) infections in infancy: epidemiological and clinical aspects

  2000cites this paper
• Influenza and respiratory syncytial virus. Update on infection, management, and prevention.

  2000cites this paper
• Vaccines for children in rich and poor countries.

  1999cites this paper
• Defense of Mucosal Surfaces: Pathogenesis, Immunity and Vaccines

  1999cites this paper
• Host responses to respiratory virus infection and immunization.

  1999cites this paper
• Identification of Multiple Protective Epitopes (Protectopes) in the Central Conserved Domain of a Prototype Human Respiratory Syncytial Virus G Protein

  1999cites this paper
• Recent developments in the biology of respiratory syncytial virus: are vaccines and new treatments just round the corner?

  1999cites this paper